Credo Technology shares have more than tripled so far in 2024.
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, Tesla, Citi, CVS, American Express, Amazon, Kroger & more
Here are the biggest calls on Wall Street on Tuesday.
Deutsche Bank bets on CVS recovery, upgrades stock to buy
The troubled pharmacy stock has slumped more than 25% in 2024.
KBW upgrades Citi, says the bank trades at a big discount to peers
Citi’s valuation relative to peers makes the stock too attractive to ignore, according to KBW.
Jefferies upgrades Kroger, says grocery store chain has upside even if Albertsons deal falls through
The firm upgraded the grocery store chain to buy from neutral.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
The S&P 500 and Nasdaq Composite rose to fresh records on Monday as December’s trading started. Here’s what CNBC is watching going into Tuesday.
Real estate stocks are starting to recover, says Janus Henderson. Here’s where it sees opportunity
The uptick in commercial real estate transactions is sione gn of an inflection point in the cycle, says Janus Henderson.
What the biggest investors are buying entering 2025 — with Trump and Fed in mind
The hedge fund community correctly nailed the election trade by piling into cyclical stocks, anticipating a rotation after Trump swept to victory.
Wells Fargo sees this biotech stock rallying 75% in its bull case
The success of one of Kymera Therapeutics’ experimental treatments could mean more upside ahead for the stock, according to Wells Fargo.
December is typically a good month for stocks, and technicians expect another good one this year
Market observers are optimistic the benchmarks could perform even better than usual this month, given what has been an atypically strong year.